A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-5968
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release ; volume:4 ; number:1 ; day:20 ; month:11 ; year:2018 ; pages:1-13 ; date:12.2018
Cell discovery ; 4, Heft 1 (20.11.2018), 1-13, 12.2018
- Urheber
-
Xu, Yiyang
Yang, Zhiyuan
Horan, Lucas H.
Zhang, Pengbo
Liu, Lianxing
Zimdahl, Bryan
Green, Shon
Lu, Jingwei
Morales, Javier F.
Barrett, David M.
Grupp, Stephan A.
Chan, Vivien W.
Liu, Hong
Liu, Cheng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41421-018-0066-6
- URN
-
urn:nbn:de:101:1-2018123019292153123944
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Xu, Yiyang
- Yang, Zhiyuan
- Horan, Lucas H.
- Zhang, Pengbo
- Liu, Lianxing
- Zimdahl, Bryan
- Green, Shon
- Lu, Jingwei
- Morales, Javier F.
- Barrett, David M.
- Grupp, Stephan A.
- Chan, Vivien W.
- Liu, Hong
- Liu, Cheng
- SpringerLink (Online service)
Ähnliche Objekte (12)
TcR
Ko-Tests: TCR
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
Combining effects of one tumor-stroma recognizing TCR with one cancer‑cell specific TCR for eradication of solid tumors
Quantifiable blood TCR repertoire components associate with immune aging
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
An intercomparison of tropospheric ozone reanalysis products from CAMS, CAMS interim, TCR-1, and TCR-2
TcR
Ko-Tests: TCR
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
Combining effects of one tumor-stroma recognizing TCR with one cancer‑cell specific TCR for eradication of solid tumors
Quantifiable blood TCR repertoire components associate with immune aging
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes
An intercomparison of tropospheric ozone reanalysis products from CAMS, CAMS interim, TCR-1, and TCR-2
TcR
Ko-Tests: TCR
Cytokines enhance human Vγ9Vδ2 T‐cell TCR‐dependent and TCR‐independent effector functions
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
HeteroTCR: A heterogeneous graph neural network-based method for predicting peptide-TCR interaction
Die Variabilität des Ratten iNKT TCR : = The variability of the rat iNKT TCR
Cross-TCR antagonism revealed by optogenetically tuning the half-life of the TCR ligand binding
TCR-like antibodies in cancer immunotherapy
Combining effects of one tumor-stroma recognizing TCR with one cancer‑cell specific TCR for eradication of solid tumors
Quantifiable blood TCR repertoire components associate with immune aging
Chronic TCR-MHC (self)-interactions limit the functional potential of TCR affinity-increased CD8 T lymphocytes